Trial Outcomes & Findings for Peripherally Inserted Internal Jugular Catheters: an Observational Study (NCT NCT03523533)
NCT ID: NCT03523533
Last Updated: 2024-03-12
Results Overview
Elapsed time from first contact of skin prep solution to completely secured/covered catheter
TERMINATED
NA
5 participants
No more than 20 minutes
2024-03-12
Participant Flow
Participant milestones
| Measure |
Peripherally-inserted Internal Jugular Catheter
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Overall Study
STARTED
|
5
|
|
Overall Study
COMPLETED
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Peripherally Inserted Internal Jugular Catheters: an Observational Study
Baseline characteristics by cohort
| Measure |
Peripherally-inserted Internal Jugular Catheter
n=5 Participants
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Age, Continuous
|
48 years
STANDARD_DEVIATION 18 • n=99 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=99 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
5 Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: No more than 20 minutesElapsed time from first contact of skin prep solution to completely secured/covered catheter
Outcome measures
| Measure |
Peripherally-inserted Internal Jugular Catheter
n=5 Participants
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Catheter Placement Time
|
5.06 minutes
Standard Deviation 0.78
|
SECONDARY outcome
Timeframe: No more than 20 minutesChoice of placement on patient's right or left side
Outcome measures
| Measure |
Peripherally-inserted Internal Jugular Catheter
n=5 Participants
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Location of Insertion
Catheter placed on patient's right side
|
5 Participants
|
|
Location of Insertion
Catheter placed on patient's left side
|
0 Participants
|
SECONDARY outcome
Timeframe: No more than 20 minutesDepth of catheter insertion in target blood vessel
Outcome measures
| Measure |
Peripherally-inserted Internal Jugular Catheter
n=5 Participants
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Depth of Insertion
|
3.4 centimeters
Standard Deviation 1.2
|
SECONDARY outcome
Timeframe: No more than 20 minutesCount of attempts to successfully place catheter
Outcome measures
| Measure |
Peripherally-inserted Internal Jugular Catheter
n=5 Participants
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Number of Attempts
|
1 Attempt
Interval 1.0 to 1.0
|
SECONDARY outcome
Timeframe: 1 weekCount of subjects experiencing complications that are related to catheter placement
Outcome measures
| Measure |
Peripherally-inserted Internal Jugular Catheter
n=5 Participants
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Number of Participants Experiencing Catheter-related Complications
Patients experiencing carotid puncture
|
0 Participants
|
|
Number of Participants Experiencing Catheter-related Complications
Patients experiencing pneumothorax
|
0 Participants
|
|
Number of Participants Experiencing Catheter-related Complications
Patients experiencing thrombosis
|
0 Participants
|
|
Number of Participants Experiencing Catheter-related Complications
Patients experiencing unexpectedly severe pain on placement
|
0 Participants
|
|
Number of Participants Experiencing Catheter-related Complications
Patients experiencing hematoma
|
0 Participants
|
|
Number of Participants Experiencing Catheter-related Complications
Patients experiencing injection-site infection
|
0 Participants
|
|
Number of Participants Experiencing Catheter-related Complications
Patients experiencing none of these complications
|
5 Participants
|
Adverse Events
Peripherally-inserted Internal Jugular Catheter
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Peripherally-inserted Internal Jugular Catheter
n=5 participants at risk
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Angiocatheter: Placement of angiocatheter in internal jugular vein
|
|---|---|
|
Product Issues
Loss of Catheter Patency
|
40.0%
2/5 • Number of events 2 • One week
|
Additional Information
Dr. Tim Petersen
University of New Mexico Health Sciences Center (HSC)
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place